Immuno-Biological Laboratories Co Ltd
TSE:4570
Immuno-Biological Laboratories Co Ltd
Net Income (Common)
Immuno-Biological Laboratories Co Ltd
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Immuno-Biological Laboratories Co Ltd
TSE:4570
|
Net Income (Common)
-¥192.7m
|
CAGR 3-Years
33%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
-6%
|
|
CMIC Holdings Co Ltd
TSE:2309
|
Net Income (Common)
¥5.3B
|
CAGR 3-Years
50%
|
CAGR 5-Years
29%
|
CAGR 10-Years
14%
|
|
Medinet Co Ltd
TSE:2370
|
Net Income (Common)
-¥1.4B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
-11%
|
|
CellSource Co Ltd
TSE:4880
|
Net Income (Common)
¥923.1m
|
CAGR 3-Years
50%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
|
Linical Co Ltd
TSE:2183
|
Net Income (Common)
¥680.4m
|
CAGR 3-Years
41%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
4%
|
|
WDB coco Co Ltd
TSE:7079
|
Net Income (Common)
¥743.6m
|
CAGR 3-Years
34%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
See Also
What is Immuno-Biological Laboratories Co Ltd's Net Income (Common)?
Net Income (Common)
-192.7m
JPY
Based on the financial report for Dec 31, 2023, Immuno-Biological Laboratories Co Ltd's Net Income (Common) amounts to -192.7m JPY.
What is Immuno-Biological Laboratories Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
-6%
Over the last year, the Net Income (Common) growth was -110%. The average annual Net Income (Common) growth rates for Immuno-Biological Laboratories Co Ltd have been 33% over the past three years , -26% over the past five years , and -6% over the past ten years .